CONTINUE TO SITE
OR WAIT 15 SECS
Singapore-based biopharmaceutical company Specialised Therapeutics (ST) has announced the Australian registrat
Taiwan-based Formosa Pharmaceuticals has entered into an exclusive licensing agreement with Adalvo Limited in
Shanghai Pharmaceutical Group and Novartis, a global pharmaceutical giant, have officially signed a strategic
RevolKa Ltd., a venture-backed biotech company providing a cutting-edge artificial intelligence (AI)-driven pr
Administered through the National Health and Medical Research Council’s (NHMRC) Clinical Trials and
Rznomics Inc., a South Korea-based biopharmaceutical startup specialising in RNA-based therapeutics, has
Olympus, a Japan-headquartered medical technology company, has announced the US FDA 510(k) clearance of its EZ
United Imaging and HKSH Medical Group have announced the signing of a Memorandum of Understanding (MoU), marki
Taiwan headquartered Bora Biologics, a leading contract development and manufacturing organization (CDMO)
Sanyou Biopharmaceuticals Co. and TransRecoBio Biotechnology Co. have signed a strategic cooperation agreement
APAC Vaccine Powerhouses Flex Capacity & Quality Muscle
Asia is the epicentre of global vaccine manufacturing, with India and China together supplying over a billion doses annually. Now, emerging players like South Korea, Singapore, and Australia are stepping up, investing in next-gen platforms and expanding capacity to meet global demand. Let’s map the manufacturing footprint of Asia’s leading vaccine manufacturers, tracking their current capacity, expansion plans, and the strategic shifts that are transforming the region into a global vaccine production hub.
POLYMER REACTION ENGINEERING XII
ECI
eci@informz.net https://engconf.us/conferences/chemical-engineering/polymer-reaction-engineering-xii/Clearwater
